ease initiation and progression will only come from a complete appreciation of the genes that influence these steps. Identification of the variants not only provides that information, but the exact nature of the sequence Cancer directly affects at least one-third of the human population, but the inherited genetic determinants of changes responsible for the difference in trait may help to pinpoint the functional domains of the protein that cancer risk remain largely unknown. Mouse models of human cancer are helping us to understand this impact the disease pathway. More important, however, may be the knowledge of genetic interactions that disease as a complex genetic trait and thus to identify the multiple genetic variant alleles involved in pathshould emerge from these studies, since this will enable us to build a comprehensive picture of the rate-deterways that affect individual cancer susceptibility.
Introduction
The human genome project has opened a Pandora's box of tools that have been hailed as the answer to most
The Importance of Weakness of the health problems that afflict the human population.
There is substantial evidence from large scale epidemioWe now have access not only to the DNA sequence logical studies involving monozygotic and dizygotic itself, but to the many naturally occurring polymorphic twins that the risk of developing multiple cancer types genetic variants that determine our individual susceptihas a strong genetic component (Lichtenstein et al., bility to a host of common diseases, including cancer, 2000). Moreover, it has been shown that in families carcardiovascular disorders, and diabetes. The holy grail rying particular mutant alleles of "high penetrance" susof postgenome drug discovery is the identification of ceptibility genes with strong effects such as the the multiple genes that control germline predisposition neurofibromatosis type 1 (NF1) gene or breast cancer to these complex diseases, as well as individual variasusceptibility genes BRCA1 and 2, phenotypes are detion in responses to the drugs that are used in therapy. pendent upon genetic background, being most similar The promise of new diagnostic tools, preventive agents, between monozygotic twins, but differing between disand targets for drug development has attracted much tant relatives with the same mutation (Fodor et al., 1998; attention as well as many millions of private and public Nathanson et al., 2001). Genetic background in human funding dollars into the hunt for the elusive genetic culpatients is therefore able to control disease progression, prits. Is this optimism justified, or simply an overenthusias has been clearly shown in animal models (Balmain astic response to the completion of the human genome and Nagase, 1998; Nadeau, 2001), but few of these project? This review will consider the progress and pit-"weak" human susceptibility genes have been convincfalls in the search for multiple genetic variants (alleles) ingly identified. Clearly, the standard gene-hunting that influence individual susceptibility to the ravages methods that have proved so successful in the past of cancer. The parallels, both biological and genetic, to find the single genes responsible for strong familial between the processes of cancer development in huphenotypes are not readily applicable to complex dismans and mice are particularly striking, leading many eases (Risch and Merikangas, 1996) . Although the gelaboratories to exploit the mouse as a model organism netic component of risk of developing prostate cancer for the study of this complex disease. Cancer risk in has been estimated to be over 40% (Lichtenstein et al., both organisms is affected by the environment and by 2000), studies involving fairly large high risk families that genetic background, and while the major questions ultigave some initial cause for optimism have suffered from mately have to be answered in humans, the mouse offers lack of confirmation in equally large studies of other unique experimental and statistical power that can help populations (Ostrander and Stanford, 2000) . This may to unravel the complex influences of genetic backbe due to genetic heterogeneity; i.e., the causal polyground on tumor susceptibility. . This effects of the strong natural modifiers are a serious iminterpretation has disturbing implications for estimates pediment to the use of ENU for finding the multiple of the total number of tumor susceptibility genes. For variant genes that confer relatively low risk and are the several genes to be detected as a QTL, they would have subject of such interest in human populations. There is to operate in the same direction (conferring resistance or no doubt that ENU mutagenesis is an extremely powerful susceptibility), since otherwise the effects of the alleles tool for the identification of critical genes that lie on would cancel each other and the locus would be invisiparticular pathways, such as the Apc (Min) mutation ble. In principle, there should be many loci where this itself (Su et al., 1992). Studies with ENU mutagenised is actually not the case; i.e., the genome should have animals are more likely to reveal this kind of strong many clusters of alleles that do not operate in unison and mutation, partly because the postdoctoral fellow workare therefore not detected by QTL analysis. Moreover, ing on the project wants to investigate a strong effect since there is no reason a priori for clusters of modifiers rather than a modest phenotypic change that may disapto exist in the first place, there should be many singlepear during the mapping process. Clearly, ENU mutatons that also remain below the radar screen, immune genesis has a very important place in the armory of tools from detection by presently available methods. We are available to the mouse geneticist, but it is an approach faced with the frightening conclusion that there may that may more usefully be applied to the detection of be many hundreds of tumor susceptibility/resistance mutants that can be easily mapped, for example by genes, presenting us with an almost impossibly complex exploiting regions of haploid deletions within the mouse problem to resolve. Fortunately, however, several argugenome (Ramirez-Solis et al., 1995). At the very least, ments suggest that this doomsday scenario may not be use of this approach for finding tumor susceptibility correct. Many QTLs engage in genetic interactions that modifier genes could be preceded by a careful study of greatly increase their combined effects on phenotype the numbers and locations of natural modifiers in the (van Wezel et al., 1996; Fijneman et al., 1996; Nagase strains used for mutagenesis and mapping. In this way, et al., 2001). To explain these strong interactions, we a perturbation of the profile of modifier locations or would have to postulate either that all of the genes within strengths may help to localize the position of the newly one QTL interact with all of the genes in the other, or induced mutation.
that there is only a single interacting gene at each locus (or some combination of these two possibilities). At first How Many Tumor Susceptibility Genes Are There? glance, the first alternative seems unlikely, but we now At a conservative estimate, at least 100 QTLs have been know that some groups of functionally related genes mapped as tumor susceptibility loci in various models arose by gene duplication to create tandem clusters of of cancer. For example, skin cancer is controlled by related sequences. It is therefore possible that a funcalleles in at least 13 loci that are detected using interspetional "cluster" may represent a QTL that has arisen and cific (Mus spretus ϫ Mus musculus) backcross mice been subject to selection because two or more of the (Nagase et al., 1999). At least as many have been recomponent genes, or different polymorphisms within ported for lung cancer (Fijneman et al., 1998) , and inthe same gene, act additively or synergistically in the creasing numbers are being uncovered for colon, liver, same direction within a biochemical or biological pathand other malignancies (van Wezel et al., 1999). Since way. Such an arrangement would ensure that this intrathe total number of variant alleles that may act as genetic QTL interacting system has a high likelihood of being modifiers will depend on the number of strains surveyed conserved within the population, since recombination (if two strains each have the same susceptibility QTL, over short distances that would disrupt the interaction it will not be detected in crosses between these strains), is less likely to occur (Figure 1 ). An example of how such it seems likely that this number will increase, and may an intra-QTL interaction might operate was found for the Drosophila Adh gene (Stam and Laurie, 1996) (for an ultimately be at least 20-30 for each tumor system. Inter-identification of pairs of interacting genes (or clusters) detected by QTL analyses.
Genetic Interactions-Lessons from Evolutionary Genetics
The importance of genetic interactions was first emphasized in evolutionary terms by Sewell Wright. In a series of papers in the early part of the last century, summarized in 1980 (Wright, 1980), he presented his "shifting balance" theory to explain evolutionary selection as a counterpoint to the selection of single mutations according to classical Darwinian theory. By this interpretation, a selective advantage is attained when a particular combination of alleles is created by population admixture, rather than by single point mutations. This was originally founded on experimentation rather than theoretical considerations. Observations of domestic livestock suggested that overall improvement takes place not from within a particular herd, but when interbreeding takes place between herds, thus generating novel combinations of alleles. An obvious problem with this theory is that if sets of alleles are required for a novel phenotype, these sets would be disrupted by further recombi- 
